Symbol="THRX"
AssetType="Common Stock"
Name="Theseus Pharmaceuticals Inc"
Description="Theseus Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. The company is headquartered in Cambridge, Massachusetts."
CIK="1745020"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="314 MAIN STREET, SUITE 04-200, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="421821000"
EBITDA="-60493000"
PERatio="None"
PEGRatio="None"
BookValue="5.66"
DividendPerShare="0"
DividendYield="0"
EPS="-1.45"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.15"
ReturnOnEquityTTM="-0.226"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="22.29"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.04"
EVToRevenue="-"
EVToEBITDA="-0.229"
Beta="None"
num_52WeekHigh="14.77"
num_52WeekLow="4.01"
num_50DayMovingAverage="9.85"
num_200DayMovingAverage="8.41"
SharesOutstanding="43576500"
DividendDate="None"
ExDividendDate="None"
symbol="THRX"
open="9.67"
high="9.74"
low="9.34"
price="9.68"
volume="92377.00"
latest_trading_day="2023-07-07"
previous_close="9.69"
change="-0.01"
change_percent="-0.1032%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="52"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="152925"
Change_recent_avg="-0.01"
Delta_recent_avg="0.79"
Variance_recent_avg="0.4"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="1107"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0140.jpeg"
image_negative_thumbnail_id_2="152"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="982"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_positive_thumbnail_id_2="618"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
